Michelle Meyer has been awarded the Distinguished Dissertation Fellowship award for 2024-25.
Michelle’s research mostly focuses on developing novel agents and treatments for asthma, atopic dermatitis, and inflammatory bowel disease. She also works on several other research projects; for example, she uses cell-based assays to measure receptor activities and to determine the toxicity of drug compounds provided by Dr. Arnold’s group and other researchers and works on better countermeasures against chemical threat agents such as chlorine gas.
She is a co-author of 6 journal articles, has several more under review, and is a co-inventor on one patent.